title: Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.
abstract: The molecular interaction of fibroblast growth factor 23 (FGF23) and klotho is essential for physiologic regulation of phosphate balance. In the absence of klotho, the FGF23 protein cannot exert its physiologic functions, as demonstrated by in vivo mouse genetic studies. Bioactive FGF23 protein loses its phosphate lowering effects in genetically modified mice with no klotho activity. The FGF23-klotho system not only affects phosphate homeostasis but can also influence parathyroid hormone (PTH) and vitamin D activities. Dysregulation of the FGF23-klotho system is noted in a number of human acquired and genetic diseases, including chronic kidney disease. Vitamin D is a strong inducer of both FGF23 and klotho expression, while FGF23 can suppress the renal expression of 1alpha(OH)ase to reduce 1,25(OH)(2)D activity. An understanding of the complex interactions of phosphate, vitamin D and PTH with the FGF23-klotho system has paved the way to explore the therapeutic benefits of modulating the FGF23-klotho system in diseases associated with abnormal mineral ion balance. The patent (WO2009095372) under discussion proposes using fusion polypeptides to manipulate the FGF23-klotho system.
authors.affiliation: Harvard School of Dental Medicine, Department of Oral Medicine, Infection and Immunity, 190 Longwood Avenue, Boston, MA 02115, USA. mrazzaque@hms.harvard.edu
authors.forename: Mohammed S
authors.initials: MS
authors.lastname: Razzaque
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism*; D006801:Humans; D000090265:Klotho Proteins; D051379:Mice; D010281:Parathyroid Hormone / Q000378:metabolism; D010330:Patents as Topic; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism
chemical_list: C000717427:FGF23 protein, human; C000717428:Fgf23 protein, mouse; D010281:Parathyroid Hormone; D010455:Peptides; D010710:Phosphates; D014807:Vitamin D; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D005966:Glucuronidase; D000090265:Klotho Proteins
references.citation: Kidney Int. 2010 Mar;77(5):390-2
references.pmid: 20150940
references.citation: Biochem Biophys Res Commun. 2001 Feb 2;280(4):1015-20
references.pmid: 11162628
references.citation: J Endocrinol. 2007 Jul;194(1):1-10
references.pmid: 17592015
references.citation: J Am Soc Nephrol. 2007 Sep;18(9):2600-8
references.pmid: 17656479
references.citation: Kidney Int. 2009 Jun;75(11):1166-1172
references.pmid: 19225558
references.citation: Nat Genet. 2000 Nov;26(3):345-8
references.pmid: 11062477
references.citation: Biochem Biophys Res Commun. 2000 Oct 22;277(2):494-8
references.pmid: 11032749
references.citation: J Am Soc Nephrol. 2008 Dec;19(12):2342-50
references.pmid: 18753255
references.citation: Nat Rev Endocrinol. 2009 Nov;5(11):611-9
references.pmid: 19844248
references.citation: Nephrol Dial Transplant. 2009 Jan;24(1):4-7
references.pmid: 18996835
references.citation: Hum Mol Genet. 2005 Feb 1;14(3):385-90
references.pmid: 15590700
references.citation: J Cell Biol. 2008 Aug 11;182(3):459-65
references.pmid: 18678710
references.citation: J Clin Endocrinol Metab. 2010 Feb;95(2):578-85
references.pmid: 19965919
references.citation: Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):788-9
references.pmid: 17925800
references.citation: FASEB J. 2009 Nov;23(11):3702-11
references.pmid: 19584304
references.citation: FASEB J. 2009 Feb;23(2):433-41
references.pmid: 18835926
references.citation: FASEB J. 2006 Apr;20(6):720-2
references.pmid: 16436465
references.citation: Ageing Res Rev. 2007 May;6(1):73-9
references.pmid: 17353153
references.citation: Cytokine Growth Factor Rev. 2005 Apr;16(2):107-37
references.pmid: 15863029
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19796-801
references.pmid: 18056631
references.citation: J Biol Chem. 2006 Mar 10;281(10):6120-3
references.pmid: 16436388
references.citation: Am J Physiol Renal Physiol. 2009 Aug;297(2):F282-91
references.pmid: 19515808
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):407-12
references.pmid: 19966287
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6500-5
references.pmid: 11344269
references.citation: Circ Cardiovasc Genet. 2009 Dec;2(6):583-90
references.pmid: 20031638
references.citation: N Engl J Med. 2003 Apr 24;348(17):1656-63
references.pmid: 12711740
references.citation: Nature. 2006 Dec 7;444(7120):770-4
references.pmid: 17086194
references.citation: Trends Mol Med. 2006 Jul;12(7):298-305
references.pmid: 16731043
references.citation: Mol Cell Biol. 2007 May;27(9):3417-28
references.pmid: 17339340
references.citation: Curr Opin Nephrol Hypertens. 2006 Jul;15(4):437-41
references.pmid: 16775459
references.citation: Nature. 1997 Nov 6;390(6655):45-51
references.pmid: 9363890
references.citation: Curr Opin Nephrol Hypertens. 2007 Jul;16(4):311-8
references.pmid: 17565272
references.citation: Am J Physiol Renal Physiol. 2009 Mar;296(3):F470-6
references.pmid: 19019915